primary antibodies against lc3, p62, nrf2, trim16, and gapdh  (Proteintech)

Journal: Journal of Diabetes Investigation

Article Title: Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR ‐30a‐3p/ TRIM16 axis

doi: 10.1111/jdi.14116

Figure Lengend Snippet: PCR primers used in this study

Article Snippet: The renal sections, after being deparaffinized and rehydrated, were incubated overnight at 4°C with TRIM16 primary antibodies (A09514‐4, 1:500; Boster Biological Engineering Co., International Enterprise Center, Wuhan, China), Bcal‐2 (ab182858, 1:500; Abcam), and bcl‐2‐associated X protein (BAX) (ab53154, 1:500; Abcam); and P‐cadherin antibodies (ab242060, 1:500; Abcam) and N‐cadherin (ab76011, 1:500; Abcam); then incubated with Alexa Fluor 594‐conjugated (red) goat anti‐mouse IgG and Alexa Fluor 488‐conjugated (green) goat anti‐rabbit IgG (1:1000; Invitrogen, Carlsbad, CA, USA) secondary antibodies at 25°C for 1 h. Nuclei were counterstained with a Hoechst solution (Thermo Fisher Scientific, Waltham, MA, USA).

Techniques:

Journal: Journal of Diabetes Investigation

Article Title: Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR ‐30a‐3p/ TRIM16 axis

doi: 10.1111/jdi.14116

Figure Lengend Snippet: Cordyceps cicadae polysaccharides administration attenuated cell apoptosis and epithelial–mesenchymal transition in the kidneys of diabetic nephropathy mice. (a, b) At the end of 12 weeks of treatment, the expression of miR ‐30a‐3p and TRIM16 was determined in the kidney tissues of mice in each group by RT‐PCR , n = 8. (c) The protein expression level of TRIM16 in kidney tissues of mice was analyzed by western blot, n = 5. (d, e) Protein expression of TRIM16 in the kidney tissues using IHC staining, scale bar = 50 μm, n = 5. (f) TUNEL staining was used to detect cell apoptosis in the kidney tissues, scale bar, 20 μm, n = 5. (g) Protein expression of Bcl‐2 and Bax in the kidney tissues were detected by IHC staining, scale bar = 50 μm, n = 5. (h) Representative images of immunofluorescence staining for P‐cadherin (red), N‐cadherin (green), and DAPI (blue), scale bar, 50 μm, n = 5, scale bar = 20 μm. Data are expressed as mean ± SD . * P < 0.05, ** P < 0.01.

Article Snippet: The renal sections, after being deparaffinized and rehydrated, were incubated overnight at 4°C with TRIM16 primary antibodies (A09514‐4, 1:500; Boster Biological Engineering Co., International Enterprise Center, Wuhan, China), Bcal‐2 (ab182858, 1:500; Abcam), and bcl‐2‐associated X protein (BAX) (ab53154, 1:500; Abcam); and P‐cadherin antibodies (ab242060, 1:500; Abcam) and N‐cadherin (ab76011, 1:500; Abcam); then incubated with Alexa Fluor 594‐conjugated (red) goat anti‐mouse IgG and Alexa Fluor 488‐conjugated (green) goat anti‐rabbit IgG (1:1000; Invitrogen, Carlsbad, CA, USA) secondary antibodies at 25°C for 1 h. Nuclei were counterstained with a Hoechst solution (Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, Immunohistochemistry, TUNEL Assay, Staining, Immunofluorescence

Journal: Journal of Diabetes Investigation

Article Title: Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR ‐30a‐3p/ TRIM16 axis

doi: 10.1111/jdi.14116

Figure Lengend Snippet: Expression of miR‐30a‐3p and TRIM16 in MPC5 podocytes treated with high glucose. The MPC5 podocytes were treated with normal glucose, mannitol, and high glucose conditions for 6, 12, and 24 h. (a) The expression level of miR‐30a‐3p in mouse podocyte was detected by RT‐qPCR. (b, c) The mRNA and protein expression of TRIM16 was determined by RT‐PCR and western blotting. * P < 0.05, ** P < 0.01.

Article Snippet: The renal sections, after being deparaffinized and rehydrated, were incubated overnight at 4°C with TRIM16 primary antibodies (A09514‐4, 1:500; Boster Biological Engineering Co., International Enterprise Center, Wuhan, China), Bcal‐2 (ab182858, 1:500; Abcam), and bcl‐2‐associated X protein (BAX) (ab53154, 1:500; Abcam); and P‐cadherin antibodies (ab242060, 1:500; Abcam) and N‐cadherin (ab76011, 1:500; Abcam); then incubated with Alexa Fluor 594‐conjugated (red) goat anti‐mouse IgG and Alexa Fluor 488‐conjugated (green) goat anti‐rabbit IgG (1:1000; Invitrogen, Carlsbad, CA, USA) secondary antibodies at 25°C for 1 h. Nuclei were counterstained with a Hoechst solution (Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Expressing, Quantitative RT-PCR, Reverse Transcription Polymerase Chain Reaction, Western Blot

Journal: Journal of Diabetes Investigation

Article Title: Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR ‐30a‐3p/ TRIM16 axis

doi: 10.1111/jdi.14116

Figure Lengend Snippet: miR‐30a‐3p regulates TRIM16 in MPC5 podocytes. (a) TRIM16 is a predicted target of miR‐30a‐3p by TargetScan. (b) A luciferase reporter plasmid containing wildtype or mutant TRIM16 was cotransfected into MPC5 podocytes with miR‐30a‐3p or miR‐NC. Luciferase activity was determined at 48 h after transfection using the dual‐luciferase assay and was normalized to Renilla activity. (c–e) RT‐PCR and western blot analysis of TRIM16 in podocytes transfected with miR‐30a‐3p or miR‐NC or miR‐30a‐3p inhibitor or inhibitor of negative control. Data are presented as mean ± SD, n = 3. ** P < 0.01, *** P < 0.001. ## P < 0.001.

Article Snippet: The renal sections, after being deparaffinized and rehydrated, were incubated overnight at 4°C with TRIM16 primary antibodies (A09514‐4, 1:500; Boster Biological Engineering Co., International Enterprise Center, Wuhan, China), Bcal‐2 (ab182858, 1:500; Abcam), and bcl‐2‐associated X protein (BAX) (ab53154, 1:500; Abcam); and P‐cadherin antibodies (ab242060, 1:500; Abcam) and N‐cadherin (ab76011, 1:500; Abcam); then incubated with Alexa Fluor 594‐conjugated (red) goat anti‐mouse IgG and Alexa Fluor 488‐conjugated (green) goat anti‐rabbit IgG (1:1000; Invitrogen, Carlsbad, CA, USA) secondary antibodies at 25°C for 1 h. Nuclei were counterstained with a Hoechst solution (Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Luciferase, Plasmid Preparation, Mutagenesis, Activity Assay, Transfection, Reverse Transcription Polymerase Chain Reaction, Western Blot, Negative Control

Journal: Journal of Diabetes Investigation

Article Title: Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR ‐30a‐3p/ TRIM16 axis

doi: 10.1111/jdi.14116

Figure Lengend Snippet: Cordyceps cicadae polysaccharides protect mouse podocyte from high glucose induced apoptosis and epithelial–mesenchymal transition by controlling miR‐30a‐3p expression. (a) Relative miR‐30a‐3p and TRIM16 expression were detected by RT‐PCR and western blotting analysis. (b) Cell viability was determined by MTT assay. (c, d) The apoptosis of cells as detected by flow cytometry. (e) Representative images of TUNEL staining to illustrate apoptotic MPC5 podocytes in each group, cell nuclei were labeled in blue by DAPI, scale bar, 50 μm. (f) Representative immunofluorescence images of E‐cadherin (E‐cad, red) and N‐cadherin (N‐cad, green), cell nuclei were labeled in blue by DAPI, scale bar, 20 μm. Data are presented as mean ± SD, n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: The renal sections, after being deparaffinized and rehydrated, were incubated overnight at 4°C with TRIM16 primary antibodies (A09514‐4, 1:500; Boster Biological Engineering Co., International Enterprise Center, Wuhan, China), Bcal‐2 (ab182858, 1:500; Abcam), and bcl‐2‐associated X protein (BAX) (ab53154, 1:500; Abcam); and P‐cadherin antibodies (ab242060, 1:500; Abcam) and N‐cadherin (ab76011, 1:500; Abcam); then incubated with Alexa Fluor 594‐conjugated (red) goat anti‐mouse IgG and Alexa Fluor 488‐conjugated (green) goat anti‐rabbit IgG (1:1000; Invitrogen, Carlsbad, CA, USA) secondary antibodies at 25°C for 1 h. Nuclei were counterstained with a Hoechst solution (Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, MTT Assay, Flow Cytometry, TUNEL Assay, Staining, Labeling, Immunofluorescence